Neuromodulation Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Neuromodulation stocks.

Neuromodulation Stocks Recent News

Date Stock Title
Nov 1 BSX Why Boston Scientific (BSX) is a Top Growth Stock for the Long-Term
Nov 1 BSX Boston Scientific Stock Gains From Market Expansion, Innovation
Nov 1 BSX Business Update
Nov 1 BSX PAHC Stock Likely to Gain From Its Latest Acquisition of Zoetis
Nov 1 BSX Teleflex Q3 Earnings Top, Stock Falls on Lowered 2024 Revenue Outlook
Nov 1 BSX The Zacks Analyst Blog The Progressive, Qualcomm, GE Aerospace, S&P Global and Boston Scientific
Oct 31 BSX Why The Fundamentals Make Me Bullish On Boston Scientific
Oct 31 BSX OMCL Stock Soars on Q3 Earnings & Revenue Beat, '24 EPS View Raised
Oct 31 BSX Looking for a Growth Stock? 3 Reasons Why Boston Scientific (BSX) is a Solid Choice
Oct 31 BSX The Zacks Analyst Blog Highlights Amazon.com, Johnson & Johnson, Boston Scientific and Armanino Foods of Distinction
Oct 31 BSX Envista Stock Climbs on Q3 Earnings and Revenue Beat, Margins Crash
Oct 31 BSX Penumbra Q3 Earnings Beat, Margins Expand, Stock Up in After Market
Oct 31 BSX MMSI's Stock Declines Despite Q3 Earnings Beat, Higher Gross Margin
Oct 31 ZYXI Zynex's (NASDAQ:ZYXI) Soft Earnings Are Actually Better Than They Appear
Oct 31 BSX Boston Scientific’s Acurate Neo2 inferior to rival TAVR valves in study
Oct 30 BSX Top Stock Reports for Amazon.com, Johnson & Johnson and Boston Scientific
Oct 30 BSX Why is Boston Scientific Stock Trading Lower On Wednesday?
Oct 30 BSX Boston Scientific ACURATE neo2 aortic valve misses primary endpoint in trial
Oct 30 BSX Bio-Techne Tops Q1 Earnings & Revenue Estimates, Stock Up in Premarket
Oct 30 BSX DaVita Stock Declines After Q3 Earnings Miss Estimates, Margins Up
Neuromodulation

Neuromodulation is the physiological process by which a given neuron uses one or more chemicals to regulate diverse populations of neurons. This is in contrast to synaptic transmission in which an axonal terminal secretes neurotransmitters to target fast-acting receptors of only one particular partner neuron. Neuromodulators are neurotransmitters that diffuse through neural tissue to affect slow-acting receptors of many neurons. Major neuromodulators in the central nervous system include dopamine, serotonin, acetylcholine, histamine, and norepinephrine. Neuromodulators are known to have modulatory effects on target areas such as decorrelation of spiking, increase of firing rate, sharpening of spatial tuning curves, maintenance of increased spiking during working memory.A neuromodulator can be conceptualized as a neurotransmitter that is not reabsorbed by the pre-synaptic neuron or broken down into a metabolite. Such neuromodulators end up spending a significant amount of time in the cerebrospinal fluid (CSF), influencing (or "modulating") the activity of several other neurons in the brain. For this reason, some neurotransmitters are also considered to be neuromodulators, such as serotonin and acetylcholine.Neuromodulation is often contrasted with classical fast synaptic transmission. In both cases the transmitter acts on local postsynaptic receptors, but in neuromodulation, the receptors are typically G-protein coupled receptors while in classical chemical neurotransmission, they are ligand-gated ion channels. Neurotransmission that involves metabotropic receptors (like G-protein linked receptors) often also involves voltage-gated ion channels, and is relatively slow. Conversely, neurotransmission that involves exclusively ligand-gated ion channels is much faster.
A related distinction is also sometimes drawn between modulator and driver synaptic inputs to a neuron, but here the emphasis is on modulating ongoing neuronal spiking versus causing that spiking.

Browse All Tags